An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
Clinical trial NCT01743560 · COMPLETED
Trial details
- NCT number
- NCT01743560
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-31
- Primary completion
- 2016-08-15
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.